Publications by authors named "N URAKAWA"
Background: Gastrectomy for gastric cancer with duodenal invasion poses an oncologic (high positive rate of resection line infiltration) and a surgical (high risk of duodenal fistula) challenge. This study aimed to validate the safety of gastrectomy for gastric cancer with duodenal invasion.
Methods: A total of 82 patients with distal gastric cancer who underwent gastrectomy and reconstruction via the Billroth II or Roux-en-Y procedure at Kobe University Hospital between 2011 and 2021 were retrospectively reviewed.
Background/aim: Squamous cell carcinoma antigen (SCC) is widely used as a tumor marker for esophageal cancer. In this study, we investigated the relationship between SCC and long-term outcomes in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy (NAC) followed by minimally invasive esophagectomy (MIE).
Patients And Methods: Between 2010 and 2018, 124 patients with ESCC who underwent MIE after NAC (cisplatin plus 5-fluorouracil) were included.
Background: Esophagectomy with lymphadenectomy is the primary treatment for esophageal squamous cell carcinoma (ESCC). However, intensive dissection of lymph nodes (LNs) along the recurrent laryngeal nerve (RLN) is associated with RLN palsy and pulmonary complications leading to poor survival. Therefore, this study aimed identify the risk factors for LNs metastasis along the RLN in patients with ESCC.
View Article and Find Full Text PDFDevelopmental cyst is occasionally seen in children but are less common in adults. Complete removal of developmental cyst is necessary because there are risk of infection, squamous cell carcinoma, and recurrence due to incomplete resection. The best approach for resection of developmental cyst is still controversial.
View Article and Find Full Text PDFArticle Synopsis
- After esophagectomy, patients often experience anastomotic strictures that complicate food passage and increase the risk of aspiration pneumonia, potentially affecting quality of life and nutrition.
- A study of 188 patients who underwent minimally invasive esophagectomy identified that 23% developed strictures, with a significantly higher occurrence among those who had neoadjuvant chemotherapy.
- Early intervention—specifically within 69 days post-surgery—was found to be a crucial risk factor for requiring more than five balloon dilatations to treat strictures, indicating a need for careful treatment planning.